von pgd | Jan 22, 2020 | International
The heads of the FDA and NIH co-authored a letter acknowledging the therapeutic potential of LSD, MDMA, psilocybin, and ketamine. The heads of the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have acknowledged the therapeutic...
von pgd | Jan 22, 2020 | Forschung
A 2016 study found that a single dose of shrooms can significantly reduce cancer patients‘ fear of death, and a new follow-up study has found that these benefits can last for years. Nearly five years ago, a team of researchers conducted a landmark trial...
von pgd | Jan 22, 2020 | Forschung
Summary: Psychedelics, such as psilocybin, provide lasting improvements in mood and feelings of social connectedness after the effect of the drug has worn off. Source: Yale People who had recently used psychedelics such as psilocybin report a sustained improvement in...
von pgd | Jan 22, 2020 | International
The first research center of its kind in the country is bringing renewed rigor to the investigation of the drugs’ therapeutic uses. Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been...
von pgd | Jan 22, 2020 | Aktuelles
Von der illegalen Droge zum Heilmittel: Werden psychedelische Substanzen wie LSD oder „Zauberpilze“ schon bald als Arzneien gegen Depressionen, Angststörungen und Schmerzen eingesetzt? Quelle: scobel – Drogen als Medizin –...
